Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is inviting applications for the Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional), aimed at advancing research on the early detection of pancreatic ductal adenocarcinoma (PDAC) and its precursor lesions. This initiative seeks to establish multi-disciplinary teams that will identify and test biomarkers for early detection, develop molecular and imaging-based markers, and utilize machine learning for biomarker discovery, all while building a biorepository of longitudinal biospecimens. The program is critical for addressing the urgent need for early intervention in high-risk populations, with an expected ten awards available under this cooperative agreement. Interested applicants can reach out to DCP CBB at ncipcdc@nih.gov for further information, with proposals due by July 1, 2026, and anticipated project start dates set for December 1, 2026.
Eligible Applicants
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Grant Documents
No documents available for this grant.